Clinical Trial Update: Safety and Tolerability of BVS857 in Subjects With Insulin Resistance [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and tolerability of BVS857 in subjects with insulin resistance. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• BVS857

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Insulin Resistance | Phase 1 | Status: COMPLETED